(Date:5/12/2008)...all/ -- Medarex, Inc.,(Nasdaq: MEDX ) announced t...arch 31, 2008., Including a gain of $151.8 millio...million shares of Genmab A/S stock in February 200...h 31, 2008, was $103.3 million, or,$0.81 per share...r $0.88,per share for the same period in 2007. In ...
(Date:5/12/2008)...all/ -- MedCath Corporation,(Nasdaq: MDTH ), a he...are,services, predominantly the diagnosis and trea...hat Art Parker, Senior Vice-President and,Treasure...as been named,Senior Vice-President, Finance and D...le, Art will continue to oversee and direct Treasu...
(Date:5/12/2008)...swire/ -- The American,Veterinary Medical Associat...d dehorning of cattle to provide veterinarians wit... with these procedures. The revised policy,approv...tioners use any,particular method of pain manageme...ndations for consideration by practitioners when t...
(Date:5/12/2008)...Over Tobacco, WASHINGTON, May 9 /PRNewswire-USN...based organization in the country, today announces...revention and Tobacco Control,Act." The legislatio...ucts., "We encourage Congress to pass this impo...i-partisan support and could genuinely help our,pe...
Breaking Medicine News(10 mins):Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:MedCath Names Parker to New Finance Post 2Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2...cted on petrochemical workers health and their ret...arly have nearly double the death rate of those wh...pproves the existing misconception that people who...er and happier lives as a consequence. Men were f...
...ly associated with good health and vitality. Howev...the body to manufacture vitamin D. //It doesn't ta... use certainly far less than it takes to get a su... better understand the complex motivations involve...
...in is being hailed as a new 'wonder drug' after it...cancer patients. New results of the trials show th...or the cancer, something that has never happened s...h tracked 5,000 patients in 39 countries, research...
...urvey conducted by Synovate India and sponsored by...gh Indians use high quality toothbrush and the lat...l of oral hygiene awareness was surprisingly low. ...tted that they have never been to a dentist in the...
Other Medicine News:(Date:5/8/2008)...ovement in ADHD symptoms in adults, WASHINGTON, M...,Nasdaq: SHPGY), the global specialty biopharmace...hase III pivotal study in which VYVANSE,demonstrat...yperactivity,Disorder (ADHD) symptoms in adults an... with ADHD often find it challenging to focus and ...
(Date:5/8/2008)...FirstCall/ -- Siemens Healthcare and,Laboratory Co...y announced,that they have entered a non-exclusive...evelop new clinical diagnostic tests in the areas ...logy and diabetes. Under the,agreement, initial di...could make the biggest impact to patient care., (...
(Date:5/8/2008)...eeting of the American Pain Society ...wswire/ -- Patients treated with lacosamide,demons...thic pain (DNP),compared to placebo-treated patie...l meeting of the American Pain Society (APS) in Ta...trial of a diabetic neuropathic,pain treatment pro...
(Date:5/8/2008)...-FirstCall/ -- AstraZeneca (NYSE:,AZN) today annou...lication,(sNDA) to the U.S. Food and Drug Administ...ate) Extended-Release Tablets to seek approval for...D), including maintenance of,antianxiety effect. I...n,atypical antipsychotic medicine in GAD. The subm...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8McMaster test detects the most prevalent respiratory viruses 10289 1McMaster test detects the most prevalent respiratory viruses 10289 2Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 1Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 2Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 1Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2... and ENMD-1198,Highlighted at Oncology Drug Discov...Newswire-FirstCall/ --,EntreMed, Inc., a clinical-...cs for the treatment of cancer and inflammatory di...ative mechanism of action,data for its three lead ...-1198. These data were presented by Dr. Theresa M....
...mary Endpoint of,In-Segment Late Loss, Non-Inferio...Failure and Superiority in Major Adverse Cardiac,E...T PARK, Ill., March 24, 2007 /PRNewswire-FirstCall... U.S. pivotal clinical,trial at the of Cardiology,...monstrated the following key results: , , -- T...
Other Medicine Technology:EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 2EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 3EntreMed Presents Mechanism Data for Its Three Lead Oncology,Compounds 4Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 2Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 3Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 4Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 5...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: